No image

Xpert BCR-ABL Ultra

GXBCRABL-US-10 · Cepheid

Xpert BCR-ABL Ultra test; 10 test kit

Details

Device typePhiladelphia chromosome/BCR-ABL mRNA expression IVD, kit, nucleic acid technique (NAT): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of mRNA expression of the Philadelphia chromosome, resulting from translocation t(9;22)(q34; q11) and rearrangement of the BCR and ABL genes, to diagnose, monitor or predict chronic myeloid leukaemia (CML) and/or a subset of acute lymphoblastic leukaemia (ALL) in a clinical specimen, using a nucleic acid technique (NAT).

FDA categoryBcr/Abl1 Monitoring Test

Device ID07332940007102

Catalog numberGXBCRABL-US-10

AvailabilityPrescription

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone1 888 838 3222

Emailtechsupport@cepheid.com

Related products

Product	Model	Company	Device type
Xpert BCR-ABL IS Panel C130MmqciPhiladelphia chromosome/BCR-ABL transcript IVD, control	v.00	Mmqci	Philadelphia chromosome/BCR-ABL transcript IVD, control
Birlinn BCR-ABL1 p210 IS Panel C230MmqciPhiladelphia chromosome/BCR-ABL transcript IVD, control	v.00	Mmqci	Philadelphia chromosome/BCR-ABL transcript IVD, control
ipsogen® JAK2 RGQ PCR KitQIAGEN GmbHJAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT)	V1	QIAGEN GmbH	JAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT)
cobas® EGFR Mutation Test v2Roche Molecular Systems, Inc.Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	2.0	Roche Molecular Systems, Inc.	Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)